日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial

采用 CHOP 方案联合抗 CD20 疗法治疗滤泡性淋巴瘤:SWOG S0016 试验的 15 年随访

Shadman, Mazyar; LeBlanc, Michael; Rimsza, Lisa; Leonard, John P; Smith, Sonali M; Li, Hongli; Friedberg, Jonathan W

Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

2024年国际滤泡性淋巴瘤科学研讨会的共识建议

Merryman, Reid; Rutherford, Sarah C; Ansell, Stephen; Armand, Philippe; Leonard, John P; Nastoupil, Loretta; Smith, Sonali M; Timmerman, John; Zelenetz, Andrew D; Gutierrez, Meghan; Béguelin, Wendy; Casulo, Carla; Cerhan, James; Green, Michael; Kahl, Brad; Kridel, Robert; Link, Brian; Maurer, Matthew J; Nadel, Bertrand; Radtke, Andrea J; Luttwak, Efrat; Salles, Gilles; Sehn, Laurie; Pasqualucci, Laura; LaCasce, Ann S

MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma

对于套细胞淋巴瘤,以微小残留病灶(MRD)为导向的初始治疗方案为阿卡替尼联合来那度胺加利妥昔单抗或奥妥珠单抗。

Ruan, Jia; Bond, David A; Shah, Bijal; Allan, John N; Rutherford, Sarah C; Gribbin, Caitlin; Chen, Zhengming; Bhinder, Bhavneet; Tam, Wayne; Rossi, Davide; Xiang, Jenny; Hobbie, Brittany; Harbhajan, Melinda; Sahni, Tejasvi K; Chen, Gui Z; Sigouros, Michael; Inghirami, Giorgio; Chen-Kiang, Selina; Elemento, Olivier; Maddocks, Kami; Leonard, John P; Martin, Peter

Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826

在S1826研究中入组的晚期经典型霍奇金淋巴瘤老年患者中,纳武利尤单抗-AVD方案与布伦妥昔单抗-AVD方案的比较

Rutherford, Sarah C; Li, Hongli; Herrera, Alex F; LeBlanc, Michael; Ahmed, Sairah; Davison, Kelly; Parsons, Susan K; Unger, Joseph M; Perry, Anamarija M; Casulo, Carla; Bartlett, Nancy L; Tuscano, Joseph M; Hess, Brian T; Torka, Pallawi; Kumar, Pankaj; Jacobs, Ryan; Song, Joo Y; Castellino, Sharon M; Kahl, Brad; Leonard, John P; Smith, Sonali M; Friedberg, Jonathan W; Evens, Andrew M

Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022

在 RELATIVITY-022 研究中,Nivolumab 联合 relatlimab 用于治疗复发或进展性 B 细胞恶性肿瘤患者

Gopal, Ajay K; Armand, Philippe; Neelapu, Sattva S; Bartlett, Nancy L; Spurgeon, Stephen E; Kuruvilla, John; Savage, Kerry J; Leonard, John P; Gelb, Arnold B; Ahmed, Nasir; Dong, Shiqi; Bathena, Sai Praneeth; Suryawanshi, Rasika; Wu, Jenny Qun; Wang, Sheen; Gladstone, Douglas E

Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium

滤泡性淋巴瘤伴POD24的治疗模式和结果:来自LEO联盟的分析

Day, Jonathan R; Larson, Melissa C; Durani, Urshila; Koff, Jean L; Wang, Yucai; Habermann, Thomas M; Lossos, Izidore S; Nastoupil, Loretta J; Strouse, Christopher; Chihara, Dai; Martin, Peter; Leonard, John P; Cohen, Jonathon B; Kahl, Brad S; Ruan, Jia; Burack, W Richard; Friedberg, Jonathan W; Cerhan, James R; Flowers, Christopher R; Link, Brian K; Maurer, Matthew J; Casulo, Carla

Comparison of Survivorship Care Guidelines for Patients With Lymphoma: Recommendations for Harmonization and Future Research Agenda

淋巴瘤患者生存期护理指南比较:协调建议和未来研究议程

Valcarcel, Bryan; Savage, Kerry J; Link, Brian K; Leonard, John P; Kelly, Kara M; Thanarajasingam, Gita; Cerhan, James R; Pro, Barbara; Gordon, Leo I; Thompson, Carrie A; Smith, Sonali M; Morton, Lindsay M

Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy: Alliance 151930, a secondary analysis of the phase III trial CALGB 50303

年龄和体能状态与接受一线 R-CHOP 治疗的弥漫性大 B 细胞淋巴瘤老年患者不良事件的关联:Alliance 151930,一项 III 期试验 CALGB 50303 的二次分析

Morrison, Vicki A; Le-Rademacher, Jennifer; Bobek, Olivia; Satele, Daniel; Leonard, John P; Jatoi, Aminah

Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201

伊布替尼加入标准预处理方案,并作为自体造血干细胞移植后复发或难治性活化B细胞型弥漫性大B细胞淋巴瘤的维持治疗:美国多中心双盲随机III期研究Alliance A051301/BMT-CTN 1201的主要分析

Andreadis, Charalambos; Bobek, Olivia; Hsi, Eric D; Fenske, Timothy S; Stiff, Patrick J; Hill, Brian T; Geyer, Susan M; Horwitz, Mitchell; Khimani, Farhad; Little, Richard F; Dinner, Shira N; Friedberg, Jonathan W; Kahl, Brad S; Perales, Miguel-Angel; Devine, Steven M; Leonard, John P; Bartlett, Nancy L

Nodal T-Cell Lymphoma Transdifferentiated from Mantle Cell Lymphoma with Epstein-Barr Virus Infection

由 Epstein-Barr 病毒感染引起的套细胞淋巴瘤转分化为结内 T 细胞淋巴瘤

Barone, Paul D; Tam, Wayne; Geyer, Julia T; Leonard, John P; Phillips, Adrienne; Ouseph, Madhu M